Boston Scientific (BSX) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 21.2% | 21.6% | 24.2% | 23.5% | 25.4% | 23.1% | ||
| Changes by years, y/y, % | +6pp | +0pp | +3pp | -1pp | +2pp | +10.8% | |||
Boston Scientific. EBITDA margin, %
Boston Scientific. EBITDA margin, changes, pp
Boston Scientific (BSX) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 26.1% | 27.0% | 27.0% | 25.0% | 30.8% | 23.1% | |
| Changes by years, y/y, % | +1pp | +7pp | +2pp | +2pp | +5pp | |||
| Changes by quarters, q/q, % | +3pp | +1pp | 0pp | -2pp | +6pp | |||